Ekström K, Lehtonen J, Nordenswan H-K, et al. Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries. Eur Heart J. 2019;40:3121–8. https://doi.org/10.1093/eurheartj/ehz428.

Article  PubMed  Google Scholar 

Birnie DH, Nery PB, Ha AC, Beanlands RSB. Cardiac Sarcoidosis. J Am Coll Cardiol. 2016;68:411–21. https://doi.org/10.1016/j.jacc.2016.03.605.

Article  PubMed  Google Scholar 

Patel MR, Cawley PJ, Heitner JF, et al. Detection of Myocardial Damage in Patients with Sarcoidosis. Circulation. 1969;2009:120. https://doi.org/10.1161/CIRCULATIONAHA.109.851352.

Article  Google Scholar 

Perry A, Vuitch F. Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med. 1995;119:167–72.

CAS  PubMed  Google Scholar 

Tschöpe C, Cooper LT, Torre-Amione G, Van Linthout S. Management of Myocarditis-Related Cardiomyopathy in Adults. Circ Res. 2019;124:1568–83. https://doi.org/10.1161/CIRCRESAHA.118.313578.

Article  CAS  PubMed  Google Scholar 

Leone O, Veinot JP, Angelini A, et al. 2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. Cardiovasc Pathol. 2012;21:245–74. https://doi.org/10.1016/j.carpath.2011.10.001.

Article  PubMed  Google Scholar 

Caforio ALP, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34:2636–48. https://doi.org/10.1093/eurheartj/eht210.

Article  PubMed  Google Scholar 

Tschöpe C, Ammirati E, Bozkurt B, et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol. 2021;18:169–93.

Article  PubMed  Google Scholar 

Krejci J, Mlejnek D, Sochorova D, Nemec P. Inflammatory Cardiomyopathy: A Current View on the Pathophysiology, Diagnosis, and Treatment. BioMed Res Int. 2016:1–11. https://doi.org/10.1155/2016/4087632.

Korosoglou G, Giusca S, Montenbruck M, et al. Fast Strain-Encoded Cardiac Magnetic Resonance for Diagnostic Classification and Risk Stratification of Heart Failure Patients. JACC Cardiovasc Imaging. 2021;14:1177–88. https://doi.org/10.1016/j.jcmg.2020.10.024.

Article  PubMed  Google Scholar 

Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357:2153–65. https://doi.org/10.1056/NEJMra071714.

Article  CAS  PubMed  Google Scholar 

Okada DR, Bravo PE, Vita T, et al. Isolated cardiac sarcoidosis: A focused review of an under-recognized entity. J Nucl Cardiol. 2018;25:1136–46. https://doi.org/10.1007/s12350-016-0658-1.

Article  PubMed  Google Scholar 

Birnie DH, Sauer WH, Bogun F, et al. HRS Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated With Cardiac Sarcoidosis. Heart Rhythm. 2014;11:1304–23. https://doi.org/10.1016/j.hrthm.2014.03.043.

Article  Google Scholar 

Terasaki F, Azuma A, Anzai T, et al. JCS 2016 Guideline on Diagnosis and Treatment of Cardiac Sarcoidosis. Circ J. 2019;83:2329–88. https://doi.org/10.1253/circj.CJ-19-0508.

Article  PubMed  Google Scholar 

Kusano KF, Satomi K. Diagnosis and treatment of cardiac sarcoidosis. Heart (British Cardiac Society). 2016;102:184–90. https://doi.org/10.1136/heartjnl-2015-307877.

Article  CAS  PubMed  Google Scholar 

McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599–726. https://doi.org/10.1093/eurheartj/ehab368.

Article  CAS  PubMed  Google Scholar 

• Kouranos V, Tzelepis GE, Rapti A, et al. Complementary Role of CMR to Conventional Screening in the Diagnosis and Prognosis of Cardiac Sarcoidosis. JACC Cardiovasc Imaging. 2017;10:1437–47. https://doi.org/10.1016/j.jcmg.2016.11.019. This paper demonstrates, that CMR is the most valuable diagnostic test compared to electrocardiography and echogardiography to diagnose CS and provides prognostic information.

Article  PubMed  Google Scholar 

Ferreira VM, Schulz-Menger J, Holmvang G, et al. Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. J Am College Cardiol. 2018:72. https://doi.org/10.1016/J.JACC.2018.09.072.

Aitken M, Chan MV, Urzua Fresno C, et al. Diagnostic Accuracy of Cardiac MRI versus FDG PET for Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis. Radiology. 2022;304:566–79. https://doi.org/10.1148/radiol.213170.

Article  PubMed  Google Scholar 

Waki H, Eguchi K, Toriumi S, et al. Isolated Cardiac Sarcoidosis Mimicking Arrhythmogenic Right Ventricular Cardiomyopathy. Int Med (Tokyo, Japan). 2018;57:835–9. https://doi.org/10.2169/internalmedicine.9395-17.

Article  Google Scholar 

Narula N, Iannuzzi M. Sarcoidosis: Pitfalls and Challenging Mimickers. Front Med. 2020;7:594275. https://doi.org/10.3389/fmed.2020.594275.

Article  Google Scholar 

Oyama-Suzuki K, Fukushima K, Egi R, et al. Cardiac Sarcoidosis Mimicking Anterior Myocardial Infarction. Ann Nucl Cardiol. 2021;7:73–6. https://doi.org/10.17996/anc.21-00136.

Article  PubMed  PubMed Central  Google Scholar 

• Pöyhönen P, Nordenswan H-K, Lehtonen J, et al. Cardiac magnetic resonance in giant cell myocarditis: a matched comparison with cardiac sarcoidosis. Eur Heart J - Cardiovasc Imaging. 2023;24:404–12. https://doi.org/10.1093/ehjci/jeac265. This paper indicates that CS can mimic other cardiac diseases espacially giant cell myocarditis.

Article  PubMed  PubMed Central  Google Scholar 

Takemura K, Nakamura R, Shimazu K, et al. A case of cardiac sarcoidosis mimicking cardiac amyloidosis on cardiovascular magnetic resonance. ESC Heart Fail. 2018;5:306–10. https://doi.org/10.1002/ehf2.12263.

Article  PubMed  PubMed Central  Google Scholar 

Bobbio E, Bollano E, Oldfors A, et al. Phenotyping of giant cell myocarditis versus cardiac sarcoidosis using cardiovascular magnetic resonance. Int J Cardiol. 2023;387:131143. https://doi.org/10.1016/j.ijcard.2023.131143.

Article  PubMed  Google Scholar 

Mahrholdt H, Wagner A, Judd RM, et al. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J. 2005;26:1461–74. https://doi.org/10.1093/eurheartj/ehi258.

Article  PubMed  Google Scholar 

Smedema J-P, Snoep G, van Kroonenburgh MPG, et al. Evaluation of the Accuracy of Gadolinium-Enhanced Cardiovascular Magnetic Resonance in the Diagnosis of Cardiac Sarcoidosis. J Am Coll Cardiol. 2005;45:1683–90. https://doi.org/10.1016/j.jacc.2005.01.047.

Article  PubMed  Google Scholar 

Flamée L, Symons R, Degtiarova G, et al. Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis. Eur Radiol. 2020;30:3702–10. https://doi.org/10.1007/s00330-020-06765-1.

Article  PubMed  Google Scholar 

Greulich S, Deluigi CC, Gloekler S, et al. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging. 2013;6:501–11. https://doi.org/10.1016/j.jcmg.2012.10.021.

Article  PubMed  Google Scholar 

Agoston-Coldea L, Kouaho S, Sacre K, et al. High mass (>18g) of late gadolinium enhancement on CMR imaging is associated with major cardiac events on long-term outcome in patients with biopsy-proven extracardiac sarcoidosis. Int J Cardiol. 2016;222:950–6. https://doi.org/10.1016/j.ijcard.2016.07.233.

Article  PubMed  Google Scholar 

Magnocavallo M, Vetta G, Polselli M, et al. “Function follows form”: Role of cardiac magnetic resonance for ventricular arrhythmia risk stratification in patients with cardiac sarcoidosis. J Cardiovasc Electrophysiol. 2023;34:1781–4. https://doi.org/10.1111/jce.16020.

Article  PubMed  Google Scholar 

•• Stevenson A, Bray JJH, Tregidgo L, et al. Prognostic Value of Late Gadolinium Enhancement Detected on Cardiac Magnetic Resonance in Cardiac Sarcoidosis. JACC Cardiovasc Imaging. 2023;16:345–57. https://doi.org/10.1016/j.jcmg.2022.10.018. In this meta-analysis of Stevenson et al. late gadolinum enhancement results in increased odds of ventricular arrhythmia and all-cause mortality with additional prognostic information in case of biventricular involvement.

Article  PubMed  Google Scholar 

• Gowani Z, Habibi M, Okada DR, et al. Utility of Cardiac Magnetic Resonance Imaging Versus Cardiac Positron Emission Tomography for Risk Stratification for Ventricular Arrhythmias in Patients With Cardiac Sarcoidosis. Am J Cardiol. 2020;134:123–9. https://doi.org/10.1016/j.amjcard.2020.08.007. This work showed that late gadolinum enhancement is one of the most important features to predict ventricular arrhythmia and is superior to inflammation in 1818FDG PET-CT.

Article  PubMed  Google Scholar 

Velangi PS, Chen K-HA, Kazmirczak F, et al. Right Ventricular Abnormalities on Cardiovascular Magnetic Resonance Imaging in Patients With Sarcoidosis. JACC Cardiovasc Imaging. 2020;13:1395–405. https://doi.org/10.1016/J.JCMG.2019.12.011.

Article  PubMed  PubMed Central  Google Scholar 

• Wang J, Zhang J, Hosadurg N, et al. Prognostic Value of RV Abnormalities on CMR in Patients With Known or Suspected Cardiac Sarcoidosis. JACC Cardiovasc Imaging. 2023;16:361–72. https://doi.org/10.1016/j.jcmg.2022.11.012.  This work highlights the prognostic importance to monitor and assess RV abnormalities

Article  CAS  PubMed  Google Scholar 

Moon JC, Messroghli DR, Kellman P, et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson. 2013;15:92. https://doi.org/10.1186/1532-429X-15-92.

Article  PubMed  PubMed Central  Google Scholar 

Haaf P, Garg P, Messroghli DR, et al. Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review. J Cardiovasc Magn Reson. 2016;18:89. https://doi.org/10.1186/s12968-016-0308-4.

Article  PubMed  PubMed Central  Google Scholar 

Messroghli DR, Moon JC, Ferreira VM, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imagi. J Cardiovasc Magn Reson. 2017;19:75.